Dr. Turban’s clinical research interests include the regulation of blood pressure and prevention of kidney disease, particularly the effects of sodium and potassium on blood pressure and on kidney function. She is the Principal Investigator of the completed American Heart Association-funded Chronic Kidney Disease-Potassium (CKD-K) clinical trial, which investigated the effects of dietary potassium in patients with kidney disease. She is also a Co-Investigator of several other research studies, including an intervention trial investigating the safety and efficacy of a vasopressin receptor antagonist in polycystic kidney disease, the NIH/NIDDK-sponsored Chronic Renal Insufficiency Cohort (CRIC) study, and an NIH-sponsored set of trials investigating the efficacy of tailored dietary advice and mineral supplements on lowering blood pressure.
Learn more about clinical trials at Johns Hopkins Medicine.
Edgar R Miller; Stephen P Juraschek; Cheryl A Anderson; Eliseo Guallar; Karen Henoch-Ryugo; Jeanne Charleston; Sharon Turban; Michael R Bennett; Lawrence J Appel; The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: results of the GO-FISH trial. Diabetes care 2013;36(6):1462-9. 2013
Sharon Turban; Carol B Thompson; Rulan S Parekh; Lawrence J Appel; Effects of sodium intake and diet on racial differences in urinary potassium excretion: results from the Dietary Approaches to Stop Hypertension (DASH)-Sodium trial. American journal of kidney diseases : the official journal of the National Kidney Foundation 2013;61(1):88-95. 2013
Q Chen; S Turban; E R Miller; L J Appel; The effects of dietary patterns on plasma renin activity: results from the Dietary Approaches to Stop Hypertension trial. Journal of human hypertension 2012;26(11):664-9. 2012
John Hayes; Kamyar Kalantar-Zadeh; Jun L Lu; Sharon Turban; John E Anderson; Csaba P Kovesdy; Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race. Nephron. Clinical practice 2012;120(1):c8-16. 2012
Matthew R Weir; Raymond R Townsend; Jeffrey C Fink; Valerie Teal; Stephen M Sozio; Cheryl A Anderson; Lawrence J Appel; Sharon Turban; Jing Chen; Jiang He; et al. Urinary sodium is a potent correlate of proteinuria: lessons from the chronic renal insufficiency cohort study. American journal of nephrology 2012;36(5):397-404. 2012
Birju Patel; Sharon Turban; Cheryl Anderson; Jeanne Charleston; Edgar R Miller; Lawrence J Appel; A comparison of web sites used to manage and present home blood pressure readings. Journal of clinical hypertension (Greenwich, Conn.) 2010;12(6):389-95. 2010
Sharon Turban; Edgar R Miller; Brett Ange; Lawrence J Appel; Racial differences in urinary potassium excretion. Journal of the American Society of Nephrology : JASN 2008;19(7):1396-402. 2008
Sharon Turban; Paul J Thuluvath; Mohamed G Atta; Hepatorenal syndrome. World journal of gastroenterology : WJG 2007;13(30):4046-55. 2007
S Turban; K T Beutler; R G Morris; S Masilamani; R A Fenton; M A Knepper; R K Packer; Long-term regulation of proximal tubule acid-base transporter abundance by angiotensin II. Kidney international 2006;70(4):660-8. 2006
Sharon Turban; Xiao-Yan Wang; Mark A Knepper; Regulation of NHE3, NKCC2, and NCC abundance in kidney during aldosterone escape phenomenon: role of NO. American journal of physiology. Renal physiology 2003;285(5):F843-51. 2003
Kathleen T Beutler; Shyama Masilamani; Sharon Turban; Jakob Nielsen; Heddwen L Brooks; Shana Ageloff; Robert A Fenton; Randall K Packer; Mark A Knepper; Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension 2003;41(5):1143-50. 2003
S Turban; F Fuentes; L Ferlic; R Brugada; A M Gotto; C M Ballantyne; A J Marian; A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin. Atherosclerosis 2001;154(3):633-40. 2001